Elisa Biasco

520 total citations
19 papers, 336 citations indexed

About

Elisa Biasco is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Elisa Biasco has authored 19 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Elisa Biasco's work include Prostate Cancer Treatment and Research (9 papers), Renal cell carcinoma treatment (6 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Elisa Biasco is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Renal cell carcinoma treatment (6 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). Elisa Biasco collaborates with scholars based in Italy, Netherlands and China. Elisa Biasco's co-authors include Luca Galli, Alfredo Falcone, Lisa Derosa, Romano Danesi, Marzia Del Re, Ron HN van Schaik, Cinzia Orlandini, Stefania Crucitta, Guido Jenster and Mario Miccoli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Elisa Biasco

18 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Biasco Italy 7 187 157 156 91 26 19 336
Mersedeh Rohanizadegan United States 7 164 0.9× 168 1.1× 128 0.8× 46 0.5× 27 1.0× 14 336
Naomi L. Sharma United Kingdom 7 305 1.6× 222 1.4× 119 0.8× 73 0.8× 30 1.2× 12 452
Guilherme Harada Brazil 11 161 0.9× 90 0.6× 66 0.4× 155 1.7× 16 0.6× 40 317
Julie Huang United States 10 106 0.6× 114 0.7× 91 0.6× 57 0.6× 28 1.1× 19 435
Marie Hjälm-Eriksson Sweden 8 367 2.0× 87 0.6× 111 0.7× 113 1.2× 31 1.2× 17 455
Vincent Verschaeve Belgium 9 147 0.8× 157 1.0× 59 0.4× 112 1.2× 6 0.2× 21 389
Letizia Laera Italy 12 179 1.0× 101 0.6× 72 0.5× 119 1.3× 11 0.4× 32 329
V. Papadimitrakopoulou United States 13 304 1.6× 223 1.4× 110 0.7× 313 3.4× 23 0.9× 41 606
Ana Teresa Martins Portugal 14 140 0.7× 285 1.8× 139 0.9× 91 1.0× 8 0.3× 25 486
Harlinde De Schutter Belgium 9 64 0.3× 179 1.1× 144 0.9× 97 1.1× 28 1.1× 12 360

Countries citing papers authored by Elisa Biasco

Since Specialization
Citations

This map shows the geographic impact of Elisa Biasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Biasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Biasco more than expected).

Fields of papers citing papers by Elisa Biasco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Biasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Biasco. The network helps show where Elisa Biasco may publish in the future.

Co-authorship network of co-authors of Elisa Biasco

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Biasco. A scholar is included among the top collaborators of Elisa Biasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Biasco. Elisa Biasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Caffo, Orazio, Gaetano Facchini, Elisa Biasco, et al.. (2019). Activity and Safety of Metronomic Cyclophosphamide in the Modern Era of Metastatic Castration-Resistant Prostate Cancer. Future Oncology. 15(10). 1115–1123. 11 indexed citations
2.
Re, Marzia Del, Stefania Crucitta, Giuliana Restante, et al.. (2018). Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment. Critical Reviews in Oncology/Hematology. 125. 51–59. 7 indexed citations
3.
Sbrana, Andrea, Elisa Biasco, Claudia Caserta, et al.. (2018). Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience. Anticancer Research. 38(8). 4913–4918. 3 indexed citations
4.
Sbrana, Andrea, Andrea Antonuzzo, Luca Galli, et al.. (2018). A case of a patient with severe renal failure on hemodialysis treated with vismodegib for relapsing basal cell carcinoma. Tumori Journal. 104(6). NP2–NP4. 2 indexed citations
5.
Caffo, Orazio, Viviana Frantellizzi, Luca Galli, et al.. (2018). Sequencing radium 223 (RA223) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the daily practice: Preliminary results from a retrospective study in Italian centers.. Journal of Clinical Oncology. 36(6_suppl). 322–322. 1 indexed citations
6.
Procopio, Giuseppe, Michele Prisciandaro, Roberto Iacovelli, et al.. (2017). Safety and efficacy of Cabozantinib for metastatic renal cell carcinoma (mRCC): real world data from an Italian Expanded Access Program (EAP). Annals of Oncology. 28. v319–v320. 1 indexed citations
7.
Maruzzo, Marco, Luca Galli, Elisa Biasco, et al.. (2017). Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis. European Journal of Cancer. 72. S190–S190. 1 indexed citations
8.
Re, Marzia Del, Elisa Biasco, Stefania Crucitta, et al.. (2016). AR-V7 detection in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer. Annals of Oncology. 27. vi248–vi248. 1 indexed citations
9.
10.
Re, Marzia Del, Elisa Biasco, Stefania Crucitta, et al.. (2016). The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. European Urology. 71(4). 680–687. 224 indexed citations
11.
Antonuzzo, Andrea, Enrico Vasile, Andrea Sbrana, et al.. (2016). Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care. Supportive Care in Cancer. 25(1). 209–212. 17 indexed citations
12.
13.
Derosa, Lisa, Annalisa Guida, Laurence Albigès, et al.. (2015). New prognostic factors for second-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC). Annals of Oncology. 26. vi53–vi53. 1 indexed citations
14.
Marconcini, Riccardo, Stefano Ricci, Luca Galli, et al.. (2015). 2311 Evaluation of predictive factors of efficacy of Somatostatin Analogs (SSA) in Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET): a single centre experience. European Journal of Cancer. 51. S436–S436. 1 indexed citations
15.
Biasco, Elisa, Andrea Antonuzzo, Luca Galli, et al.. (2015). Small-Bowel Neuroendocrine Tumor and Retroperitoneal Fibrosis: Efficacy of Octreotide and Tamoxifen. Tumori Journal. 101(1). e24–e28. 7 indexed citations
16.
Biasco, Elisa, et al.. (2014). Early and Prolonged Response to Pazopanib in a Patient with Multiple Metastases from Renal Cell Carcinoma: A Case Report. Tumori Journal. 100(3). e83–e86. 1 indexed citations
17.
18.
19.
Orlandi, Paola, Andrea Fontana, Antonio Fioravanti, et al.. (2013). VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide. British Journal of Cancer. 109(4). 957–964. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mersedeh Rohanizadegan Breakdown of academic impact, for papers by Naomi L. Sharma Breakdown of academic impact, for papers by Guilherme Harada Breakdown of academic impact, for papers by Julie Huang Breakdown of academic impact, for papers by Marie Hjälm-Eriksson Breakdown of academic impact, for papers by Vincent Verschaeve Breakdown of academic impact, for papers by Letizia Laera Breakdown of academic impact, for papers by V. Papadimitrakopoulou Breakdown of academic impact, for papers by Ana Teresa Martins Breakdown of academic impact, for papers by Harlinde De Schutter
Rankless by CCL
2026